Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Catalyst Pharmaceuticals Inc’s stock clocked out at $20.38, down -0.44% from its previous closing price of $20.47. In other words, the price has decreased by -$0.44 from its previous closing price. On the day, 0.68 million shares were traded. CPRX stock price reached its highest trading level at $20.4758 during the session, while it also had its lowest trading level at $20.05.
Ratios:
To gain a deeper understanding of CPRX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.07. For the most recent quarter (mrq), Quick Ratio is recorded 4.94 and its Current Ratio is at 5.14. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 14, 2024, initiated with a Buy rating and assigned the stock a target price of $27.
On March 07, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $23.
On December 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $30.Oppenheimer initiated its Outperform rating on December 21, 2023, with a $30 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 21 ’24 when Tierney David S sold 15,000 shares for $20.10 per share. The transaction valued at 301,455 led to the insider holds 348,874 shares of the business.
Miller Steve sold 150,000 shares of CPRX for $3,052,900 on Aug 20 ’24. The Chief Op. & Scientific Officer now owns 675,124 shares after completing the transaction at $20.35 per share. On Aug 21 ’24, another insider, Tierney David S, who serves as the Director of the company, bought 15,000 shares for $20.10 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CPRX now has a Market Capitalization of 2429540352 and an Enterprise Value of 2046542336. As of this moment, Catalyst’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.20, and their Forward P/E ratio for the next fiscal year is 14.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.57 while its Price-to-Book (P/B) ratio in mrq is 3.97. Its current Enterprise Value per Revenue stands at 4.71 whereas that against EBITDA is 16.713.
Stock Price History:
Over the past 52 weeks, CPRX has reached a high of $20.87, while it has fallen to a 52-week low of $11.55. The 50-Day Moving Average of the stock is 18.38%, while the 200-Day Moving Average is calculated to be 30.27%.
Shares Statistics:
It appears that CPRX traded 1.10M shares on average per day over the past three months and 1008720 shares per day over the past ten days. A total of 107.12M shares are outstanding, with a floating share count of 102.35M. Insiders hold about 13.77% of the company’s shares, while institutions hold 74.91% stake in the company. Shares short for CPRX as of 1723680000 were 5054616 with a Short Ratio of 4.58, compared to 1721001600 on 5346208. Therefore, it implies a Short% of Shares Outstanding of 5054616 and a Short% of Float of 5.29.
